SCHEMBL9145265

SCHEMBL9145265

CC(=O)Oc1ccc2c(c1)CC[C@@H]1[C@@H]2CC[C@]2(C)[C@@]3(O)C=C[C@]12C[C@@H]3O

nearest known ligand 0.56

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SMN1; SMN2 Q16637 4/20 0.56
LMNA P02545 4/20 0.56
ESR1 P03372 4/20 0.56
ADORA3 P0DMS8 3/20 0.56
ATM Q13315 2/20 0.56
PGR P06401 1/20 0.56
AR P10275 1/20 0.56
CHRM1 P11229 1/20 0.56
TBXA2R P21731 1/20 0.56
ADRA1A P35348 1/20 0.56
OPRM1 P35372 1/20 0.56
SLC6A3 Q01959 1/20 0.56
MAPT P10636 3/20 0.50
CYP3A4 P08684 2/20 0.50
TP53 P04637 1/20 0.50
AKR1C3 P42330 1/20 0.44
RECQL P46063 2/20 0.44
BLM P54132 1/20 0.44
KMT2A Q03164 2/20 0.44
NR3C1 P04150 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8959363 1.00 SMN1; SMN2 (0.56) SMN1; SMN2LMNAESR1ADORA3ATM
SCHEMBL8959356 0.89 SMN1; SMN2 (0.58) SMN1; SMN2LMNAESR1ADORA3ATM
SCHEMBL9147068 0.88 LMNA (0.53) SMN1; SMN2LMNAESR1ADORA3ATM
SCHEMBL8959344 0.88 LMNA (0.53) SMN1; SMN2LMNAESR1ADORA3ATM
SCHEMBL8959384 0.88 LMNA (0.53) SMN1; SMN2LMNAESR1ADORA3ATM
SCHEMBL8959354 0.84 ESR1 (0.50) SMN1; SMN2LMNAESR1ADORA3PGR
SCHEMBL9146982 0.84 ESR1 (0.50) SMN1; SMN2LMNAESR1ADORA3PGR
SCHEMBL8959391 0.84 ESR1 (0.50) SMN1; SMN2LMNAESR1ADORA3PGR
SCHEMBL8959346 0.84 ESR1 (0.50) SMN1; SMN2LMNAESR1ADORA3PGR
SCHEMBL9144814 0.83 LMNA (0.58) SMN1; SMN2LMNAESR1ADORA3ATM

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0513947-B1 14 Alpha, 16alpha-ethano- and 14alpha, 16alpha ethenoestratrienes SCHERING AG (DE) 1995-11-15 EP disclosed
US-5439902-A Estrogen therapy, birth control SCHERING AKTIENGESELLSCHAFT (DE) 1995-08-08 US disclosed
EP-0513947-A1 14 Alpha, 16alpha-ethano- and 14alpha, 16alpha ethenoestratrienes SCHERING AKTIENGESELLSCHAFT (DE) 1992-11-19 EP disclosed